SARS-CoV2 in different body fluids, risks of transmission, and preventing COVID-19: A comprehensive evidence-based review

Kutti-Sridharan, Gurusaravanan; Vegunta, Rathnamitreyee; Vegunta, Radhakrishna; Mohan, Babu P.; Rokkam, Venkata Ram Pradeep

doi:10.4103/ijpvm.ijpvm_255_20

Cited by 20 publications

(1 citation statement)

References 55 publications

(73 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The viral infection is known to spread by aerosol particles <5 µm and droplets >5 µm in size. 4 - 6 Endoscopic procedures have been adjusted to prevent human-to-human transmission. 7 For treating patients with COVID-19, full personal protective equipment is mandatory for endoscopists and other healthcare personnel.…”

Section: Introductionmentioning

confidence: 99%

Aerosol protection using modified N95 respirator during upper gastrointestinal endoscopy: a randomized controlled trial

et al. 2024

View full text Add to dashboard Cite

Aerosol protection using modified N�� respirator during upper gastrointestinal endoscopy: a randomized controlled trial This modified N�� respirator had tendency to reduce particles, especially the particle size of �.�-µm generated in upper gastrointestinal endoscopy The standard N�� respirator (�M Aura ��+ model) was modified to create a channel for endoscope insertion. All patients aged �� and above with undetectable COVID-�� virus who underwent diagnostic upper gastrointestinal endoscopy were enrolled and randomly assigned in �:� ratio into the modified N�� group and control (no mask) group.

show abstract

Section: Introductionmentioning

confidence: 99%

Aerosol protection using modified N95 respirator during upper gastrointestinal endoscopy: a randomized controlled trial

et al. 2024

View full text Add to dashboard Cite

show abstract

Health disparity and COVID‐19—A retrospective analysis

Sarkar

Taylor

Dutta

et al. 2021

Health Science Reports

View full text Add to dashboard Cite

Background and Aims According to the World Health Organization (WHO), more than 75.7 million confirmed cases of coronavirus disease 2019 (COVID‐19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2 ( SARS‐CoV‐2), have been reported so far. Researchers are working relentlessly to find effective solutions to this catastrophe, using genomic sequence‐based investigation, immunological analysis, and more. The role of health disparity has also emerged as an intriguing factor that made a huge impact on the lives of people. Methods We analyzed various factors that triggered the health disparity in the United States of America along with the rate of COVID‐19 morbidity and mortality. Furthermore, we have also focused on the State of Mississippi, which is suffering from an extreme health disparity. Data have been obtained from publicly available data sources including, Center for Disease Control and Prevention and Mississippi State Department of Health. Correlation analysis of the dataset has been performed using R software. Results Our analysis suggested that the COVID‐19 infection rate per 100 000 people is directly correlated with the increasing number of the African American population in the United States. We have found a strong correlation between the obesity and the COVID‐19 cases as well. All the counties in Mississippi demonstrate a strong correlation between a higher number of African American population to COVID‐19 cases and obesity. Our data also indicate that a higher number of African American populations are facing socioeconomic disadvantages, which enhance their chances of becoming vulnerable to pre‐existing ailments such as obesity, type‐2 diabetes, and cardiovascular diseases. Conclusion We proposed a possible explanation of increased COVID‐19 infectivity in the African American population in the United States. This work has highlighted the intriguing factors that increased the health disparity at the time of the COVID‐19 pandemic.

show abstract

Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1

Zamzami

Rabbani²,

Ahmad

et al. 2022

Bioelectrochemistry

135

101

View full text Add to dashboard Cite

SARS-CoV2 in different body fluids, risks of transmission, and preventing COVID-19: A comprehensive evidence-based review

Cited by 20 publications

References 55 publications

Aerosol protection using modified N95 respirator during upper gastrointestinal endoscopy: a randomized controlled trial

Aerosol protection using modified N95 respirator during upper gastrointestinal endoscopy: a randomized controlled trial

Health disparity and COVID‐19—A retrospective analysis

Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1

Contact Info

Product

Resources

About